Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
about
Serological study of vaccinia virus reservoirs in areas with and without official reports of outbreaks in cattle and humans in São Paulo, BrazilPhase II randomized, double-blinded comparison of a single high dose (5×10(8) TCID50) of modified vaccinia Ankara compared to a standard dose (1×10(8) TCID50) in healthy vaccinia-naïve individuals.Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations.Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario.Cross-Neutralizing and Protective Human Antibody Specificities to Poxvirus InfectionsChallenges and Achievements in Prevention and Treatment of Smallpox.
P2860
Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
@ast
Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
@en
type
label
Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
@ast
Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
@en
prefLabel
Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
@ast
Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
@en
P2093
P2860
P356
P1476
Analysis of variola and vaccinia virus neutralization assays for smallpox vaccines.
@en
P2093
Christine M Hughes
Frances K Newman
Inger K Damon
Kevin L Karem
Robert B Belshe
Scott K Smith
Sharon E Frey
Victoria A Olson
Whitni B Davidson
P2860
P304
P356
10.1128/CVI.00056-12
P577
2012-05-16T00:00:00Z